|
1
|
Ajani JA, D'Amico TA, Bentrem DJ, Chao J,
Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, et al:
Gastric cancer, version 2.2022, NCCN clinical practice guidelines
in oncology. J Natl Compr Canc Netw. 20:167–192. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song Z, Wu Y, Yang J, Yang D and Fang X:
Progress in the treatment of advanced gastric cancer. Tumour Biol.
39:10104283177146262017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bilici A: Treatment options in patients
with metastatic gastric cancer: Current status and future
perspectives. World J Gastroenterol. 20:3905–3915. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li T, He Y, Zhong Q, Yu J and Chen X:
Advances in treatment models of advanced gastric cancer. Technol
Cancer Res Treat. 21:153303382210903532022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsieh HL, Yu MC, Cheng LC, Yeh TS and Tsai
MM: Molecular mechanism of therapeutic approaches for human gastric
cancer stem cells. World J Stem Cells. 14:76–91. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Y, Feng F and Zhou YN: Stem cells in
gastric cancer. World J Gastroenterol. 21:112–123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xue C, Sowden MP and Berk BC:
Extracellular and intracellular cyclophilin A, native and
post-translationally modified, show diverse and specific
pathological roles in diseases. Arterioscler Thromb Vasc Biol.
38:986–993. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yurchenko V, Constant S, Eisenmesser E and
Bukrinsky M: Cyclophilin-CD147 interactions: A new target for
anti-inflammatory therapeutics. Clin Exp Immunol. 160:305–317.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Obchoei S, Wongkhan S, Wongkham C, Li M,
Yao Q and Chen C: Cyclophilin A: Potential functions and
therapeutic target for human cancer. Med Sci Monit. 15:RA221–RA232.
2009.PubMed/NCBI
|
|
10
|
Han JM and Jung HJ: Cyclophilin A/CD147
interaction: A promising target for anticancer therapy. Int J Mol
Sci. 23:93412022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liao Y, Luo D, Peng K and Zeng Y:
Cyclophilin A: A key player for etiological agent infection. Appl
Microbiol Biotechnol. 105:1365–1377. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chu MY, Huang HC, Li EM and Xu LY: CypA: A
potential target of tumor radiotherapy and/or chemotherapy. Curr
Med Chem. 28:3787–3802. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cho HJ and Jung HJ: Cyclophilin A
inhibitors suppress proliferation and induce apoptosis of MKN45
gastric cancer stem-like cells by regulating CypA/CD147-mediated
signaling pathway. Int J Mol Sci. 24:47342023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han JM, Kim SM, Kim HL, Cho HJ and Jung
HJ: Natural cyclophilin A inhibitors suppress the growth of cancer
stem cells in non-small cell lung cancer by disrupting crosstalk
between CypA/CD147 and EGFR. Int J Mol Sci. 24:94372023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choi YS, Cho HJ and Jung HJ: Atorvastatin
inhibits the proliferation of MKN45-derived gastric cancer stem
cells in a mevalonate pathway-independent manner. Korean J Physiol
Pharmacol. 26:367–375. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han JM, Sohng JK, Lee WH, Oh TJ and Jung
HJ: Identification of cyclophilin A as a potential anticancer
target of novel nargenicin A1 analog in AGS gastric cancer cells.
Int J Mol Sci. 22:24732021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nawara HM, Afify SM, Hassan G, Zahra MH,
Atallah MN, Seno A and Seno M: An assay for cancer stem
cell-induced angiogenesis on chick chorioallantoic membrane. Cell
Biol Int. 45:749–756. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Palumbo C, Sisi F and Checchi M: CAM
model: Intriguing natural bioreactor for sustainable research and
reliable/versatile testing. Biology (Basel). 12:12192023.PubMed/NCBI
|
|
19
|
Wang SS, Jiang J, Liang XH and Tang YL:
Links between cancer stem cells and epithelial-mesenchymal
transition. Onco Targets Ther. 8:2973–2980. 2015.PubMed/NCBI
|
|
20
|
Peng Z, Wang CX, Fang EH, Wang GB and Tong
Q: Role of epithelial-mesenchymal transition in gastric cancer
initiation and progression. World J Gastroenterol. 20:5403–5410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia P and Xu XY: Epithelial-mesenchymal
transition and gastric cancer stem cell. Tumour Biol.
39:10104283176983732017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meng Y, Fan XY, Yang LJ, Xu BQ, He D, Xu
Z, Wu D, Wang B, Cui HY, Wang SJ, et al: Detachment activated
CyPA/CD147 induces cancer stem cell potential in non-stem breast
cancer cells. Front Cell Dev Biol. 8:5438562020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Galoczova M, Coates P and Vojtesek B:
STAT3, stem cells, cancer stem cells and p63. Cell Mol Biol Lett.
23:122018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dubrovska A, Kim S, Salamone RJ, Walker
JR, Maira SM, García-Echeverría C, Schultz PG and Reddy VA: The
role of PTEN/Akt/PI3K signaling in the maintenance and viability of
prostate cancer stem-like cell populations. Proc Natl Acad Sci USA.
106:268–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tanabe S, Quader S, Cabral H and Ono R:
Interplay of EMT and csc in cancer and the potential therapeutic
strategies. Front Pharmacol. 11:9042020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jia M, Wang Y, Guo Y, Yu P, Sun Y, Song Y
and Zhao L: Nitidine chloride suppresses epithelial-mesenchymal
transition and stem cell-like properties in glioblastoma by
regulating JAK2/STAT3 signaling. Cancer Med. 10:3113–3128. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu J, Liu D, Niu H, Zhu G, Xu Y, Ye D, Li
J and Zhang Q: Resveratrol reverses doxorubicin resistance by
inhibiting epithelial-mesenchymal transition (EMT) through
modulating PTEN/Akt signaling pathway in gastric cancer. J Exp Clin
Cancer Res. 36:192017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Becerril-Rico J, Alvarado-Ortiz E,
Toledo-Guzmán ME, Pelayo R and Ortiz-Sánchez E: The cross talk
between gastric cancer stem cells and the immune microenvironment:
A tumor-promoting factor. Stem Cell Res Ther. 12:4982021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y and Weinberg RA:
Epithelial-to-mesenchymal transition in cancer: Complexity and
opportunities. Front Med. 12:361–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ru NY, Wu J, Chen ZN and Bian H:
HAb18G/CD147 is involved in TGF-β-induced epithelial-mesenchymal
transition and hepatocellular carcinoma invasion. Cell Biol Int.
39:44–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu X, Tang Z, Jiang X, Wang T, Zhao L, Xu
Z and Liu K: Cyclophilin A/CD147 signaling induces the
epithelial-to-mesenchymal transition and renal fibrosis in chronic
allograft dysfunction by regulating p38 MAPK signaling. Ren Fail.
44:1585–1594. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sadrkhanloo M, Entezari M, Orouei S,
Ghollasi M, Fathi N, Rezaei S, Hejazi ES, Kakavand A, Saebfar H,
Hashemi M, et al: STAT3-EMT axis in tumors: Modulation of cancer
metastasis, stemness and therapy response. Pharmacol Res.
182:1063112022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mirzaei S, Saghari S, Bassiri F, Raesi R,
Zarrabi A, Hushmandi K, Sethi G and Tergaonkar V: NF-κB as a
regulator of cancer metastasis and therapy response: A focus on
epithelial-mesenchymal transition. J Cell Physiol. 237:2770–2795.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu H, Ma J, Li Z, Ding Z, Chen W, Peng Y,
Tao Z, Chen L, Luo M, Wang C, et al: CyPA interacts with SERPINH1
to promote extracellular matrix production and inhibit
epithelial-mesenchymal transition of trophoblast via enhancing
TGF-β/Smad3 pathway in preeclampsia. Mol Cell Endocrinol.
548:1116142022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yamamoto T, Takakura H, Mitamura K and
Taga A: Cyclophilin a knokdown inhibits cell migration and invasion
through the suppression of epithelial-mesenchymal transition in
colorectal cancer cells. Biochem Biophys Res Commun. 526:55–61.
2020. View Article : Google Scholar : PubMed/NCBI
|
